Cover Image
市場調查報告書

多囊性卵巢症:全球臨床試驗回顧(2011年下半期)

Polycystic Ovarian Syndrome Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 217852
出版日期 內容資訊 英文 270 Pages
訂單完成後即時交付
價格
Back to Top
多囊性卵巢症:全球臨床試驗回顧(2011年下半期) Polycystic Ovarian Syndrome Global Clinical Trials Review, H2, 2015
出版日期: 2015年12月04日 內容資訊: 英文 270 Pages
簡介

本報告針對全球各國多囊性卵巢症臨床實驗進行調查,提供地區・進展狀況・級別(期)、募集狀況分類實施數量、具代表性贊助商、開發中的治療藥物資料、各企業機關進行狀況,目錄介紹如下。

目錄

介紹

  • 多囊性卵巢症
  • 本報告構成

地區分類臨床實驗數量

  • 國家分類臨床實驗數量
    • 亞太地區頂尖國家
    • 歐洲頂尖國家
    • 北美頂尖國家
    • 中東・非洲頂尖國家
    • 中南美頂尖國家

BRIC各國臨床實驗數量

G7各國臨床實驗數量

  • G7各國臨床實驗數量:臨床實驗情況分類

E7各國臨床實驗數量

  • E7各國臨床實驗數量:臨床實驗情況分類

級別分類臨床實驗數量

  • 進行中臨床實驗數量:等級分類

進捗状況別の治験件数

未達成的臨床實驗數量

限定期間選用的實驗者數量

知名贊助商

  • 參加多囊性卵巢症臨床實驗的知名贊助商

著名治療藥物比較

臨床實驗分析

  • 頂尖企業臨床實驗概況
    • Biocinese
    • CATALYSIS, S.L
    • Eugonia
    • Ferring Pharmaceuticals, Inc.
    • UMC Utrecht
    • Merck KGaA
    • Shire Plc
  • 頂尖大學・研究機關・醫院臨床實驗概況
    • University of Virginia
    • University Magna Graecia
    • Penn State University
    • Hvidovre University Hospital
    • Mansoura University
    • Odense University Hospital
    • University of California, San Diego
    • Royan Institute
    • Yale University
    • Taipei Medical University Hospital
    • Adelaide Colorectal Cancer Collaborative
    • Heilongjiang university of Chinese medicine
    • Taipei Medical University WanFang Hospital
    • Gulhane School of Medicine
    • S.C.Das Memorial Medical & Research Centre
    • University of California, Davis
    • University of Rochester
    • Emory University
    • Goteborg University
    • Skejby Hospital

5項代表性臨床實驗分析

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3024CTIDB

GlobalData's clinical trial report, "Polycystic Ovarian Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Polycystic Ovarian Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Polycystic Ovarian Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Polycystic Ovarian Syndrome to Women's Health Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Polycystic Ovarian Syndrome to Women's Health Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Polycystic Ovarian Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials by Region, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Polycystic Ovarian Syndrome to Women's Health Clinical Trials, G7 Countries (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Polycystic Ovarian Syndrome to Women's Health Clinical Trials, E7 Countries (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Polycystic Ovarian Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Polycystic Ovarian Syndrome to Women's Health Clinical Trials, G7 Countries (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Polycystic Ovarian Syndrome to Women's Health Clinical Trials, E7 Countries (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Polycystic Ovarian Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Polycystic Ovarian Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Polycystic Ovarian Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top